Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

A woman developed lupus after taking hydroxyurea for two years.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Dutasteride improved both hair loss and acne in two young men.

"Flosin – Prostamol Uno" effectively manages BPH symptoms with fewer side effects.

Baricitinib may effectively treat oral lichen planus.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.